CellVoyant

CellVoyant is an AI-first biotechnology company dedicated to accelerating the development of therapies to cure chronic diseases. The company employs live cell imaging combined with artificial intelligence to predict and optimize stem cell differentiation. This approach aims to enable advanced cell analytics and process development, facilitating the controllable manufacturing of various cells and tissues at scale. Working at the nexus of cell biology, computer vision, engineering, and machine learning, CellVoyant brings innovative solutions to the field of biotechnology. The company is backed by leading venture capital firms and renowned investors in AI and biotech, grounding its efforts in robust scientific and commercial expertise.